Suppr超能文献

一种用于物理化学/药物代谢动力学/毒理学分析的分级筛选方法。

A hierarchical screening methodology for physicochemical/ADME/Tox profiling.

作者信息

DeWitte Robert S, Robins Russell H

机构信息

New Pharma R&D Solutions, Thermo Electron Corporation, 5344 John Lucas Drive, Burlington, Ontario L7L 6A6, Canada.

出版信息

Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):805-17. doi: 10.1517/17425255.2.5.805.

Abstract

Full integration of pharmaceutical profiling into pharmaceutical lead selection and optimisation requires that complete sets of unequivocal data be available at the time compound design or advancement decisions are made. As the productivity of chemical synthesis expands, and the breadth of profiling assays grow in scope, physicochemical/ADME/Tox laboratories are being challenged to produce ever more data to support an accelerating decision cycle. This article focuses on the challenges of increasing preclinical profiling productivity while managing lower accuracy higher throughput data streams to preserve confidence in decision making. The authors propose a hierarchical screening strategy and describe the implementation of an automated system designed to support that strategy efficiently.

摘要

将药物特征分析全面整合到药物先导物的选择和优化过程中,需要在做出化合物设计或推进决策时能够获得完整且明确的数据集。随着化学合成效率的提高以及特征分析检测范围的扩大,物理化学/药物代谢动力学/毒理学实验室面临着挑战,需要生成更多数据以支持加速的决策周期。本文重点探讨了在管理准确性较低但通量较高的数据流以维持决策信心的同时,提高临床前特征分析效率所面临的挑战。作者提出了一种分层筛选策略,并描述了一个旨在有效支持该策略的自动化系统的实施情况。

相似文献

1
A hierarchical screening methodology for physicochemical/ADME/Tox profiling.
Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):805-17. doi: 10.1517/17425255.2.5.805.
2
Applications of high-throughput ADME in drug discovery.
Curr Opin Chem Biol. 2004 Jun;8(3):339-45. doi: 10.1016/j.cbpa.2004.04.015.
3
Computational chemistry as an integral component of lead generation.
Mini Rev Med Chem. 2005 Jul;5(7):677-83. doi: 10.2174/1389557054368826.
4
Systems-ADME/Tox: resources and network approaches.
J Pharmacol Toxicol Methods. 2006 Jan-Feb;53(1):38-66. doi: 10.1016/j.vascn.2005.05.005. Epub 2005 Jul 27.
5
Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
Curr Top Med Chem. 2001 Nov;1(5):403-25. doi: 10.2174/1568026013395001.
6
Implementation of an ADME enabling selection and visualization tool for drug discovery.
J Pharm Sci. 2004 May;93(5):1131-41. doi: 10.1002/jps.20020.
7
In silico ADME-Tox modeling: progress and prospects.
Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1147-1158. doi: 10.1080/17425255.2017.1389897. Epub 2017 Oct 13.
8
Perspectives on bioanalytical mass spectrometry and automation in drug discovery.
Curr Drug Metab. 2008 Nov;9(9):986-94. doi: 10.2174/138920008786485173.
9
Computational methods to estimate drug development parameters.
Curr Opin Drug Discov Devel. 2001 Jan;4(1):102-9.
10
Utility of mass spectrometry for in-vitro ADME assays.
Curr Drug Metab. 2006 Jun;7(5):467-77. doi: 10.2174/138920006777697954.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验